These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4176266)

  • 1. Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis.
    Papadimitriou M; Gingell JC; Chisholm GD
    Lancet; 1968 Nov; 2(7575):948-50. PubMed ID: 4176266
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcaemia from calcium resin in patients with chronic renal failure.
    Sevitt LH; Wrong OM
    Lancet; 1968 Nov; 2(7575):950-1. PubMed ID: 4176267
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypercalcaemia from calcium resin.
    Bone JM; Davison AM
    Lancet; 1968 Nov; 2(7578):1137. PubMed ID: 4177178
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia from calcium resin.
    Knapp MS; Heath DA
    Lancet; 1968 Nov; 2(7578):1136-7. PubMed ID: 4177177
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin.
    Labeeuw M; Cabanne JF
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):316-9. PubMed ID: 4018932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcaemia from calcium resin.
    Swales JD; Sevitt LH; Wrong OM
    Lancet; 1969 Mar; 1(7593):532. PubMed ID: 4179606
    [No Abstract]   [Full Text] [Related]  

  • 7. The preferred phosphate binder in dialysis patients.
    Gokal R
    Perit Dial Int; 1999; 19(5):405-8. PubMed ID: 11379851
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypercalcaemic crises in patients with chronic renal failure caused by ion-exchange resins, antacidotics and other calcium-containing drugs (author's transl)].
    Graben N; Cremer W; Anlauf M; Bock KD
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1903-7. PubMed ID: 598299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with ion exhcange resins in the calcium phase during the management of hyperkalemia].
    Ritz E; Fanz HE; Herzfeld G
    Dtsch Med Wochenschr; 1969 Jan; 94(2):75-7. PubMed ID: 5782694
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hyperkalemia with a calcium-resin.
    Berlyne GM; Janabi K; Shaw AB; Hocken AG
    Lancet; 1966 Jan; 1(7430):169-72. PubMed ID: 4164888
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminium resin for the treatment of the hyperkalamia of renal failure.
    Chugh KS; Swales JD; Brown CL; Wrong OM
    Lancet; 1968 Nov; 2(7575):952-3. PubMed ID: 4176268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercalcemic crises in patients with chronic kidney failure due to calcium-containing ion-exchangers, antacids and other drugs].
    Graben N; Cremer W; Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1505-8. PubMed ID: 1030032
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis.
    Ginsburg DS; Kaplan EL; Katz AI
    Lancet; 1973 Jun; 1(7815):1271-4. PubMed ID: 4126071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aluminum hydroxide treatment of hyperphosphatemia in uremia].
    Bergquist-Poppen M; Bergström J; Wallin R
    Lakartidningen; 1972 May; 69(19):2319-20. PubMed ID: 5035811
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient and persistent hypercalcaemia in patients treated by maintenance haemodialysis.
    Wing AJ; Curtis JR; Eastwood JB; Smith EK; de Wardener HE
    Br Med J; 1968 Oct; 4(5624):150-2. PubMed ID: 5681049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exchangeable potassium study in patients undergoing chronic haemodialysis.
    Seedat YK
    Br Med J; 1969 May; 2(5653):344-5. PubMed ID: 5768459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle).
    Frohnert PP; Johnson WJ; Mueller GJ; Tauxe WN; McCall JT
    J Lab Clin Med; 1968 May; 71(5):840-6. PubMed ID: 5647685
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin A toxicity and hypercalcaemia in chronic renal failure.
    Farrington K; Miller P; Varghese Z; Baillod RA; Moorhead JF
    Br Med J (Clin Res Ed); 1981 Jun; 282(6281):1999-2002. PubMed ID: 6788164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 20. Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis?
    Veighey K; Booth J; Davenport A
    Nephrol Dial Transplant; 2011 Mar; 26(3):1006-10. PubMed ID: 20736253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.